1.75 +0.15 (8.38%)
RGDX
| Trade RGDX now with |
Stock Details
Last Trade:1.75 Change:+0.15 (8.38%) Prev Close:1.60 Open: 1.79 Days Range:1.60 – 1.79 52 Week Range: 0.81 - 3.05 Volume:49881 P/E: N/AEPS:-0.14
View AllRecent Alerts 02/06/12
Recent Alert on 12/28/11 at 4:11pm
Response Genetics (RGDX) President Meda Resigns
Response Genetics (RGDX) President Meda Resigns
In a Form 8-K, Response Genetics (Nasdaq: RGDX) disclosed its President Christine Meda has resigned, effective December 31st, 2011.
Recent Alert on 12/21/11 at 11:53am
Response Genetics (RGDX) Introduces New ALK Testing Capabilities for NSCLC Tumors
Response Genetics (RGDX) Introduces New ALK Testing Capabilities for NSCLC Tumors
Recent Alert on 12/21/11 at 11:53am
Response Genetics (RGDX) Introduces New ALK Testing Capabilities for NSCLC Tumors
Response Genetics (RGDX) Introduces New ALK Testing Capabilities for NSCLC Tumors
View AllRecent Press Releases
Press Release on 02/06/12 at 7:00am
Response Genetics to Present at the 22nd Annual UBS Global Healthcare Services Conference
Response Genetics to Present at the 22nd Annual UBS Global Healthcare Services Conference
View AllRecent SEC Filings
SEC Filing on 02/06/12 at 6:04pm
Form 4 RESPONSE GENETICS INC For: Feb 02 Filed by: van den Broek Richard
Form 4 RESPONSE GENETICS INC For: Feb 02 Filed by: van den Broek Richard
View AllRecent Blog Posts
Blog Posts on 07/07/10 at 7:51am
Biomarker Diagnostics Drive Personalized Medicine but Path to Market Still Rife With Hurdles
Biomarker Diagnostics Drive Personalized Medicine but Path to Market Still Rife With Hurdles


